(Q42978490)
Statements
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO study (English)
Yuichi Ishikawa
Hitoshi Kiyoi
Keisuke Watanabe
Koichi Miyamura
Yasuyuki Nakano
Kunio Kitamura
Akio Kohno
Isamu Sugiura
Toshiya Yokozawa
Akitoshi Hanamura
Kazuhito Yamamoto
Hiroatsu Iida
Nobuhiko Emi
Kazunori Ohnishi